Moving forward with breast cancer prevention

Wendy Y. Chen, Bernard Rosner, Graham A. Colditz

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Despite randomized controlled trial data supporting the use of selective estrogen receptor modulators (SERMs) to reduce the incidence of breast cancer, to the authors' knowledge uptake has been limited. Similar to cardiovascular risk models, the routine use of breast cancer risk prevention models in the clinical setting to identify those patients at highest risk of developing breast cancer can maximize the risk-benefit ratio of SERMs and provide an impetus to move forward with implementing breast cancer prevention.

Original languageEnglish
Pages (from-to)2387-2391
Number of pages5
JournalCancer
Volume109
Issue number12
DOIs
StatePublished - Jun 15 2007
Externally publishedYes

Fingerprint Dive into the research topics of 'Moving forward with breast cancer prevention'. Together they form a unique fingerprint.

  • Cite this